<VariationArchive VariationID="503914" VariationName="NM_021939.4(FKBP10):c.831del (p.Gly278fs)" VariationType="Deletion" Accession="VCV000503914" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-23" DateCreated="2018-04-02" MostRecentSubmission="2024-03-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="495422" VariationID="503914">
      <GeneList>
        <Gene Symbol="FKBP10" FullName="FKBP prolyl isomerase 10" GeneID="60681" HGNC_ID="HGNC:18169" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="41813004" stop="41823213" display_start="41813004" display_stop="41823213" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="39968961" stop="39979468" display_start="39968961" display_stop="39979468" Strand="+" />
          </Location>
          <OMIM>607063</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_021939.4(FKBP10):c.831del (p.Gly278fs)</Name>
      <CanonicalSPDI>NC_000017.11:41819306:CCCCCCC:CCCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="41819307" stop="41819307" display_start="41819307" display_stop="41819307" variantLength="1" positionVCF="41819306" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="39975559" stop="39975559" display_start="39975559" display_stop="39975559" variantLength="1" positionVCF="39975558" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G278fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_12" sequenceAccession="LRG_12">
            <Expression>LRG_12:g.11604del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.39975565del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.39975565del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.41819313del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.41819313del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015860.1" sequenceAccession="NG_015860" sequenceVersion="1" change="g.11604del">
            <Expression>NG_015860.1:g.11604del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021939.4" sequenceAccession="NM_021939" sequenceVersion="4" change="c.831del" MANESelect="true">
            <Expression>NM_021939.4:c.831del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_068758.3" sequenceAccession="NP_068758" sequenceVersion="3" change="p.Gly278fs">
            <Expression>NP_068758.3:p.Gly278fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021939.3" sequenceAccession="NM_021939" sequenceVersion="3" change="c.831delC">
            <Expression>NM_021939.3:c.831delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA500024053" DB="ClinGen" />
        <XRef Type="rs" ID="137853883" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_021939.4(FKBP10):c.831del (p.Gly278fs) AND not provided" Accession="RCV000599070" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021939.4(FKBP10):c.831del (p.Gly278fs) AND Osteogenesis imperfecta type 11" Accession="RCV003985091" Version="1">
        <ClassifiedConditionList TraitSetID="920">
          <ClassifiedCondition DB="MedGen" ID="C3151218">Osteogenesis imperfecta type 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-06" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-04-02" MostRecentSubmission="2024-03-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22689593</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22949511</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28492130</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="920" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5698" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OI, TYPE XI</ElementValue>
                <XRef Type="MIM" ID="610968" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta, type XI</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type 11</ElementValue>
                <XRef ID="MONDO:0012592" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OI11</ElementValue>
                <XRef Type="MIM" ID="610968" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12875" />
                <XRef ID="12875" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C3151218" DB="MedGen" />
              <XRef ID="MONDO:0012592" DB="MONDO" />
              <XRef Type="MIM" ID="610968" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1390220" SubmissionDate="2019-01-29" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDX:1860536|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000710214" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.831delC variant in the FKBP10 gene has been previously reported in multiple individuals with osteogenesis imperfecta type 3 who carry a second FKBP10 pathogenic variant (Vorster et al., 2017). This deletion causes a frameshift starting with codon Glycine 278, changes this amino acid to an Alanine residue and creates a premature Stop codon at position 20 of the new reading frame, denoted p.Gly278AlafsX20. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Based on currently available evidence, we consider c.831delC to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKBP10" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_021939.3:c.831delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7982967" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4940950|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004297773" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22689593</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22949511</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28492130</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly278Alafs*20) in the FKBP10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FKBP10 are known to be pathogenic (PMID: 22689593, 22949511). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with osteogenesis imperfecta (PMID: 28492130). ClinVar contains an entry for this variant (Variation ID: 503914). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKBP10" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.39975559del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8977623" SubmissionDate="2024-03-19" DateLastUpdated="2024-03-23" DateCreated="2024-03-23">
        <ClinVarSubmissionID localKey=":Chr.17_39975558_39975559_TC_T|OMIM:610968" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004801519" DateUpdated="2024-03-23" DateCreated="2024-03-23" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The FKBP10 c.831delC (p.Gly278AlafsTer20) variant results in a frameshift and is predicted to result in a premature truncation of the protein. The p.Gly278AlafsTer20 variant has been reported in a compound heterozygous state in eight individuals with osteogenesis imperfecta, including in three siblings and in at least three different families, and in a heterozygous state in one healthy parent of an affected individual (Vorster et al. 2017; Zhang et al. 2018; Chetty et al. 2019). In the seven individuals reported by Voster et al. (2017) and Chetty et al. (2019), all of whom were from southern Africa, the p.Gly278AlafsTer20 variant was identified in trans with another frameshift variant that occurs at the same nucleotide position, c.831dupC (p.Gly278ArgfsTer95), a pathogenic variant that Voster et al. (2017) suggest to be a founder variant in black southern African populations. In the remaining case, a male of Chinese heritage, the p.Gly278AlafsTer20 variant was found in trans with a different frameshift variant (Zhang et al. 2018). Control data are unavailable for this variant, which is reported at a frequency of 0.000081 in the African population of the Genome Aggregation Database. Chetty et al. (2019) indicate that the p.Gly278AlafsTer20 variant results in the loss of two peptidylprolyl isomerase domains and two EF-hand domains, which are important for appropriate protein localization. Based on the available evidence, the c.831delC (p.Gly278AlafsTer20) variant is classified as pathogenic for osteogenesis imperfecta with or without joint contractures.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="T" referenceAllele="TC" start="39975558" stop="39975559" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610968" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14324016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8977623" TraitType="Disease" MappingType="XRef" MappingValue="610968" MappingRef="OMIM">
        <MedGen CUI="C3151218" Name="Osteogenesis imperfecta type 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7982967" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1390220" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

